Systemic Corticosteroids Are NOT Recommended for Viral Sinusitis
Oral corticosteroids (Medrol dose pack or prednisone) should NOT be used for symptomatic relief of viral sinusitis. The most recent 2025 American Academy of Otolaryngology-Head and Neck Surgery guidelines explicitly discourage systemic steroids for this indication, recommending instead topical intranasal corticosteroids, analgesics, and nasal saline irrigation 1, 2.
Why Systemic Steroids Are Not Appropriate
The 2025 guidelines specifically identify systemic steroids as having "questionable, unknown or unproven efficacy" for both viral rhinosinusitis (VRS) and acute bacterial rhinosinusitis (ABRS), and actively recommend discouraging their use 1, 2. This represents a clear quality improvement opportunity to avoid interventions that lack evidence of benefit.
Key Reasoning:
- Viral sinusitis is self-limited, typically peaking within 3 days and resolving within 10-14 days without intervention 1
- No high-quality evidence supports systemic steroids for viral sinusitis specifically
- The available research on systemic steroids (showing modest benefit) was conducted in patients receiving antibiotics, suggesting bacterial rather than viral disease 3
- Topical intranasal steroids are preferred when corticosteroid therapy is desired, with a number needed to treat of 13 and a favorable safety profile 1
What TO Recommend Instead
For symptomatic relief of viral sinusitis, offer:
Topical intranasal corticosteroids - Low burden of risk, NNT of 13, with longer courses and higher doses showing greater effect 1
Analgesics - NSAIDs for malaise, sneezing, headache, and ear pain; acetaminophen for nasal obstruction and rhinorrhea 1
Nasal saline irrigation - Higher volume irrigations may be superior, with low risk of adverse effects 1
Short-term topical decongestants - Oxymetazoline for up to 3-5 days maximum (warn about rebound congestion beyond 3 days) 1
Critical Pitfalls to Avoid
Do not confuse viral with bacterial sinusitis. Bacterial sinusitis requires either:
- Symptoms persisting ≥10 days without improvement, OR
- "Double worsening" - initial improvement followed by worsening within 10 days 2, 4
Nasal purulence alone does NOT indicate bacterial infection - it simply reflects neutrophil presence from inflammation 1.
The Evidence on Systemic Steroids
While a 2011 Cochrane review found that oral corticosteroids as adjunctive therapy to antibiotics showed short-term symptom improvement (RR 1.3-1.4 at days 3-10), this evidence has significant limitations 3:
- Studies were conducted in ENT specialty clinics with radiologically-confirmed disease
- All participants received antibiotics, suggesting bacterial rather than viral etiology
- No long-term data on relapse or recurrence
- Significant risk of attrition bias
- Quality rated as only moderate
The 2025 guidelines supersede this older evidence and explicitly recommend against systemic steroids based on the aggregate evidence quality being insufficient and the balance of benefit-to-harm being unfavorable 1, 2.
Bottom Line
Reserve systemic corticosteroids for appropriate indications (such as chronic rhinosinusitis with nasal polyps or severe acute exacerbations), not for routine viral upper respiratory infections presenting as sinusitis. The risks of systemic steroids - even short courses - include mood disturbances, insomnia, gastrointestinal effects, and HPA axis suppression 5, 6, 7. These risks are not justified when effective, safer alternatives exist for viral sinusitis.